Comparing reported side effects of semaglutide and tirzepatide using FDA safety data

Comparative post-marketing safety data for semaglutide and tirzepatide remain limited.

• Semaglutide and tirzepatide are both utilized for managing type 2 diabetes and obesity.
• There is a need for more comprehensive safety evaluations of these medications in real-world settings.
• Current safety data primarily derive from clinical trials, which may not fully capture long-term effects.

Simplified